SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is experiencing a significant upward momentum, driven by continued tech sector strength, early positive mega-cap earnings, and a weakening dollar pushing it towards new all-time highs. The market community is sharply divided between fomo-driven bulls celebrating 

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

ASML is experiencing significant market attention as investors keenly await its earnings, propelled by expectations of massive bookings and optimistic analyst outlooks tied to the accelerating AI-driven semiconductor demand and robust capital expenditure plans from key customers. While many laud its crucial near-monopoly in advanced chipmaking, the community also debates its high valuation and the long-term implications of rising geopolitical tensions and reports of China's indigenous EUV technology development. The company remains a central figure in the broader chip equipment sector, reflecting confidence in the ongoing AI supercycle.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is capturing market attention with investors celebrating new all-time highs and the ongoing expansion of its AI and high-performance computing data center infrastructure. The community is buzzing with anticipation for new hyperscaler lease announcements, driving discussions around potential further upside and a significant short squeeze. Despite some caution regarding volatility, the prevailing sentiment highlights APLD's strong position in the high-demand data center sector.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

The SPDR S&P 500 ETF Trust is actively trending as it repeatedly reaches new all-time highs, propelled by robust mega-cap tech earnings and a positive market outlook ahead of key economic announcements. While many investors are celebrating the strong upward momentum and dismissing bearish sentiment, a skeptical segment of the community questions the sustainability of this rally amidst discussions around a weakening dollar and potential overextension. This creates a clear divide between those riding the current market surge and others anticipating a significant market adjustment.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is currently seeing elevated chatter and investor optimism following reports of China approving the import of its H200 AI chips, signaling a potential new revenue stream. The community is actively discussing a possible 'gamma squeeze' and a breakout to new highs, driven by ongoing demand for AI infrastructure and anticipated strong capital expenditure from upcoming big tech earnings. Many anticipate the stock to overcome current resistance levels, reinforcing its leadership position in the burgeoning AI sector.

Richtech Robotics, Inc. engages in the development of robotics and artificial intelligence. The firm designs, manufactures, and sells robots to restaurants, hotels, senior living centers, casinos, factories, and movie theaters. Its robots perform a variety of services including restaurant running and bussing, hotel room service delivery, floor scrubbing and vacuuming, and beverage and food preparation. The company was founded by Zhen Wu Huang and Zhen Qiang Huang on July 19, 2016 and is headquartered in Las Vegas, NV.

Richtech Robotics Inc. - Ordinary Shares - Class B

Richtech Robotics Inc.

Richtech Robotics Inc. ($RR) is generating significant market buzz after announcing a collaboration with Microsoft's AI Co-Innovation Labs to integrate Azure-powered agentic AI into its ADAM robots. This news is driving strong speculation within the community, with many anticipating substantial growth in the AI and robotics sector while others express caution regarding the partnership's full implications and potential for price volatility.

Stride, Inc. is a technology-based educational company, which engages in the provision of proprietary and third-party curriculum, software systems and educational services. It also offers online curriculum and career services to middle and high school students, under the Destinations Career Academy brand name. The company was founded by Ronald J. Packard in 2000 and is headquartered in Reston, VA.

Stride Inc

Stride Inc. is trending strongly following an impressive earnings report that surpassed estimates with significant enrollment growth, particularly in Career Learning. The company also authorized a substantial stock repurchase program, sparking widespread community discussion about its undervalued position. Many are now discussing a potential short squeeze, given previous short interest and the company's strong performance in the expanding digital education space.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending sharply lower following a government proposal for a significantly reduced 2027 Medicare Advantage payment rate, which overshadowed its recent earnings beat and raised concerns over future profitability. Community discussion is split between those who see this as an exaggerated market reaction and a prime buying opportunity, and others who anticipate further declines amidst speculation of political market manipulation and a shifting view of healthcare stocks.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is currently trending following a $75 million direct offering to an institutional investor, intended to fully fund its Phase 3 MASH trial, which has sparked mixed community reactions concerning dilution versus strategic positioning. This capital raise, coupled with a new 'Overweight' rating and $20 price target from Barclays and recent FDA Breakthrough Therapy Designation for pemvidutide, is fueling intense speculation around a potential short squeeze, partnership, or outright acquisition within the MASH and weight loss sector.

JD.com, Inc. is a technology-driven E-commerce company, which engages in the sale of electronics products and general merchandise products, including audio, video products, and books. It operates in the following segments: JD Retail, JD Logistics, and New Businesses. The JD Retail segment offers online retail, online marketplace, and marketing services. The JD Logistics segment includes internal and external logistics businesses. The New Businesses segment is composed of JD Property, Jingxi, overseas businesses and technology initiatives. The company was founded on June 18, 1998, by Qiang Dong Liu and is headquartered in Beijing, China.

JD.com Inc - ADR

JD.com is trending amid widespread investor frustration over its sustained underperformance compared to other Chinese tech stocks and the broader market. Despite aggressive share buybacks and a substantial cash pile, many in the community feel the stock is being artificially suppressed, particularly around options expiration, while its long-term value from its logistics moat and AI investments is overlooked. The ongoing debate centers on whether the current extreme undervaluation will finally lead to a significant catch-up rally for the e-commerce giant.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insider Selling: Sionna Therapeutics (NASDAQ:SION) Major Shareholder Sells 250,000 Shares of Stock

Sionna Therapeutics, Inc. (NASDAQ:SION - Get Free Report) major shareholder Tpg Gp A, Llc sold 250,000 shares of the stock in a transaction that occurred on Thursday, January 22nd. The shares were...

Tpg Gp A, Llc Sells 250,000 Shares of Sionna Therapeutics (NASDAQ:SION) Stock

Sionna Therapeutics, Inc. (NASDAQ:SION - Get Free Report) major shareholder Tpg Gp A, Llc sold 250,000 shares of the stock in a transaction dated Thursday, January 22nd. The shares were sold at an...

Sionna Therapeutics (NASDAQ:SION) Shares Gap Down - Here's Why

Sionna Therapeutics (NASDAQ:SION) Shares Gap Down - What's Next...

Sionna Therapeutics (NASDAQ:SION) Stock Price Up 8.1% - Here's Why

Sionna Therapeutics (NASDAQ:SION) Trading Up 8.1% - Here's What Happened...

Sionna Therapeutics Chief Legal Officer Caps Off Strong 2025 with Sale of Over 10,000 Shares

Key PointsSionna Therapeutics' Chief Legal Officer sold 10,250 shares for over $400k on Dec. 5, 2025...

Sionna Therapeutics (NASDAQ:SION) Stock Price Down 10.1% - Here's What Happened

Sionna Therapeutics (NASDAQ:SION) Stock Price Down 10.1% - Here's What Happened...

Sionna Therapeutics (NASDAQ:SION) Shares Down 7.5% - What's Next?

Sionna Therapeutics (NASDAQ:SION) Stock Price Down 7.5% - Here's Why...

Sionna Therapeutics, Inc. (NASDAQ:SION) Receives Average Recommendation of "Moderate Buy" from Analysts

Shares of Sionna Therapeutics, Inc. (NASDAQ:SION - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the nine ratings firms that are presently covering the stock...

A Sionna Therapeutics (SION) Insider Sold 33,000 Shares for $1.5 Million

Key Points33,356 shares sold for a transaction value of $1,486,009.80 on Dec. 24, 2025...

Sionna Therapeutics (NASDAQ:SION) Director Peter Thompson Sells 33,356 Shares

Sionna Therapeutics, Inc. (NASDAQ:SION - Get Free Report) Director Peter Thompson sold 33,356 shares of the firm's stock in a transaction dated Wednesday, December 24th. The shares were sold at an...

Sionna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in researching, developing and commercializing novel medicines for cystic fibrosis. It is focused on advancing a robust pipeline of small molecules and complementary CFTR modulators designed to deliver transformative clinical outcomes and improve the quality of life for individuals living with cystic fibrosis. The company was founded by Greg Hurlbut and Mark Munson in August 2019 and is headquartered in Waltham, MA.

SION
Sionna Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest SION News

SIONSionna Therapeutics Inc